Colorectal cancer chemotherapy: Irinotecan

被引：0
|
作者：
Rougier, P [1 ]
Mitry, E [1 ]
机构：
[1] Hop Ambroise Pare, Dept GastroEnterol & Digest Oncol, F-92100 Boulogne, France
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 143
页数：6
相关论文
共 50 条
  • [31] Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer
    Richard M. Goldberg
    Sharlene Gill
    Cancer Chemotherapy and Pharmacology, 2004, 54 : S57 - S64
  • [32] Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancer
    Hebbar, Mohamed
    Ychou, Marc
    Ducreux, Michel
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 749 - 752
  • [33] Chemotherapy with mitomycin c and capecitabine in patients with advanced colorectal cancer pretreated with irinotecan and oxaliplatin
    Rimassa, Lorenza
    Gullo, Giuseppe
    Carnaghi, Carlo
    Abbadessa, Giovanni
    Zuradelli, Monica
    Tronconi, Maria Chiara
    Pressiani, Tiziana
    Santoro, Armando
    TUMORI, 2006, 92 (04) : 285 - 289
  • [34] Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment
    Mitry, Emmanuel
    Lievre, Astrid
    Bachet, Jean-Baptiste
    Rougier, Philippe
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (06) : 605 - 612
  • [35] Metabolic Activation of Irinotecan during Intra-arterial Chemotherapy of Metastatic Colorectal Cancer
    Czejka, M.
    Kiss, A.
    Koessner, C.
    Terkola, R.
    Ettlinger, D.
    Schueller, J.
    ANTICANCER RESEARCH, 2011, 31 (10) : 3573 - 3578
  • [36] Ocoxin oral solution® as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver
    Hernandez-Unzueta, Iera
    Benedicto, Aitor
    Olaso, Elvira
    Sanz, Eduardo
    Viera, Cristina
    Arteta, Beatriz
    Marquez, Joana
    ONCOLOGY LETTERS, 2017, 13 (06) : 4002 - 4012
  • [37] Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy
    An, Xin
    Ding, Pei-Rong
    Xiang, Xiao-Juan
    Wang, Zhi-Qiang
    Wang, Feng-Hua
    Feng, Fen
    Jiang, Wen-Qi
    He, You-Jian
    Xu, Rui-Hua
    Li, Yu-Hong
    BIOMARKERS, 2010, 15 (03) : 243 - 248
  • [38] Cetuximab and irinotecan in patients with colorectal cancer refractory to oxaliplatin and irinotecan
    Gonzalez-Baron, M.
    Blanco, M.
    Feliu, J.
    Gomez, C.
    Casado, E.
    Castro, J.
    Belda-Iniesta, C.
    Garrido, M.
    Aguayo, C.
    Campos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Irinotecan - Effective alternative in colorectal cancer
    不详
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (12) : A4 - A4
  • [40] Optimizing irinotecan regimens for colorectal cancer
    Yim, Kein-Leong
    Cunningham, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) : 560 - 561
12345